Sei Investments Co. Boosts Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Sei Investments Co. raised its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 9.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 472,169 shares of the company’s stock after acquiring an additional 40,425 shares during the period. Sei Investments Co. owned approximately 0.38% of Henry Schein worth $32,674,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Versant Capital Management Inc increased its position in shares of Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after purchasing an additional 335 shares during the last quarter. Venturi Wealth Management LLC increased its holdings in shares of Henry Schein by 3,347.1% in the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after buying an additional 569 shares during the last quarter. Quent Capital LLC raised its position in shares of Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after buying an additional 323 shares in the last quarter. Smartleaf Asset Management LLC lifted its holdings in shares of Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after acquiring an additional 143 shares during the last quarter. Finally, City State Bank purchased a new position in Henry Schein in the fourth quarter worth $55,000. Institutional investors own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on HSIC shares. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and lifted their price target for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. UBS Group cut their target price on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Jefferies Financial Group lifted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Barrington Research reaffirmed an “outperform” rating and issued a $90.00 price objective on shares of Henry Schein in a research note on Wednesday, February 26th. Finally, Mizuho started coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Henry Schein presently has a consensus rating of “Moderate Buy” and a consensus target price of $81.10.

Insider Buying and Selling

In other news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC opened at $69.38 on Wednesday. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a 50-day moving average price of $74.79 and a 200-day moving average price of $72.65. The company has a market cap of $8.62 billion, a price-to-earnings ratio of 28.55, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.49.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the previous year, the company earned $0.66 EPS. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. As a group, equities analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.